Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children

NCT01096056 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza vaccine GSK2186877A formulation 1
BIOLOGICAL: Influenza vaccine GSK2186877A formulation 2
BIOLOGICAL: Fluarix

Sponsor

GlaxoSmithKline